Sex, Ascites and Alcoholism in Survival of Patients with Cirrhosis
- 8 August 1974
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 291 (6) , 271-273
- https://doi.org/10.1056/nejm197408082910602
Abstract
The hypothesis that prednisone treatment increases the survival of female patients with compensated, nonalcoholic cirrhosis, based on a previously published controlled trial in unselected patients, was confirmed in a new series. From the total material, comprising 512 patients (old series 334 patients, new series 178 patients), it was estimated that female sex was the most positive single factor determining the effect of prednisone treatment on survival, and ascites was the most negative factor. A significant alcohol consumption tended to be a negative factor, but was too closely linked with male sex to be analyzed separately. In female patients with compensated, nonalcoholic cirrhosis prednisone treatment increased the six-year survival by one third to two thirds. In other groups of patients, comprising about 70 per cent of the material, prednisone was ineffective or possibly harmful. (N Engl J Med 291:271–273, 1974)Keywords
This publication has 6 references indexed in Scilit:
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973
- Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early PrognosisGastroenterology, 1972
- Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic HepatitisQJM: An International Journal of Medicine, 1971
- Determination of Sample Size and Selection of Cases.Published by American Psychological Association (APA) ,1959
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958